Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of β-Caryophyllene on Multiple Sclerosis
IRCT20180103038199N19Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of beta-caryophyllene in multiple sclerosis (MS), sponsored by Mashhad University of Medical Sciences. Started Aug 2025; status: recruiting.
02
Drugs
beta-caryophyllene
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20180103038199N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180103038199N19.